All Studies

Pharmaceutical agents as potential drivers in the development of Early-Onset Colorectal Cancer: A Case-Control Study.

The incidence of early-onset colorectal cancer (EOCRC) is increasing, not linked to known risk factors. Researchers hypothesize that a pharmaceutical agent may be the cause, suggesting the need for strategies to minimize this risk.

Ben-Aharon I et al (2023).
JMIR Public Health Surveill.
PubMed:
37933755

Chemical composition analysis of Angelica sinensis (Oliv.) Diels and its four processed products by ultra-high-performance liquid chromatography coupled with quadrupole-orbitrap mass spectrometry combining with nontargeted metabolomics.

Wang K et al (2023).
J Sep Sci.
PubMed:
37933715

Cassava molecular genetics and genomics for enhanced resistance to diseases and pests.

Scientists are using modern breeding techniques and molecular genetics to develop cassava varieties that are resistant to diseases and pests, which will increase productivity and food security for smallholder farmers in tropical regions.

Ntui VO et al (2023).
Mol Plant Pathol.
PubMed:
37933591

Curcumin's Dose-Dependent Attenuation of Gastric Cancer Cell Progression Via the PI3K Pathway Blockade.

Curcumin, found in turmeric, reduces gastric cancer cell growth, migration, and invasion. It suppresses the PI3K signaling pathway, making it a potential therapeutic agent for gastric cancer. Further research is needed for in vivo effectiveness.

Xi G et al (2023).
Dose Response.
PubMed:
37933268

Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer.

Bioinformatics study identifies 401 targets in cancer, MAPK signaling, and PI3K/Akt signaling pathways that Taxus chinensis (TC) binds to, potentially making it an effective treatment for lung cancer.

Zhang S, Wang J and Zhang H (2023).
Medicine (Baltimore).
PubMed:
37933017